Omeprazole suspension
Pro Research Analysisby 
Searched over 200M research papers for "omeprazole suspension"
Omeprazole Suspension: Efficacy, Safety, and Pharmacokinetics
Introduction to Omeprazole Suspension
Omeprazole suspension is a liquid formulation of the proton-pump inhibitor (PPI) omeprazole, designed to treat conditions associated with gastric hypersecretion. This formulation is particularly useful for patients who cannot swallow tablets or capsules, such as critically ill patients or children.
Efficacy in Preventing Upper Gastrointestinal Bleeding
Critically Ill Patients
Studies have demonstrated that immediate-release omeprazole suspension is effective in preventing upper gastrointestinal bleeding in critically ill patients. In a randomized, double-blind trial, omeprazole suspension was compared to intravenous cimetidine. The results showed that the rate of clinically significant bleeding was lower in the omeprazole group (4.5%) compared to the cimetidine group (6.8%), meeting the criteria for noninferiority . Additionally, omeprazole was more effective in maintaining a gastric pH of >4, which is crucial for preventing bleeding .
Stress-Related Mucosal Damage
A prospective study on mechanically ventilated patients with additional risk factors for stress-related mucosal damage found that simplified omeprazole suspension effectively prevented clinically significant upper gastrointestinal bleeding. The study reported a mean gastric pH of 6.8 after starting omeprazole, with no patients experiencing significant bleeding .
Pharmacokinetics and Administration Routes
Comparison with Capsule Form
The pharmacokinetics of omeprazole suspension differ from those of delayed-release capsules. A study involving healthy volunteers showed that the suspension had a faster absorption rate but a lower overall bioavailability compared to the capsule form. Specifically, the time to maximum concentration (tmax) was significantly shorter for the suspension, although the area under the concentration-time curve (AUC) was lower .
Administration in Critically Ill Patients
In critically ill patients, the route of administration (nasogastric, jejunal, or duodenal) of omeprazole suspension does not significantly affect its pharmacokinetic parameters or pH control. All routes maintained a mean intragastric pH of >4 for 24 hours, making the suspension a versatile option for patients with enteral tubes .
Pediatric Use and Stability
Pediatric Formulations
Omeprazole suspension is particularly beneficial for pediatric patients who require a liquid formulation. Studies have shown that omeprazole nanoparticles in suspension form are effective in treating gastric hypersecretion in children, providing a stable and effective therapeutic option . Additionally, the suspension maintains its stability and efficacy when stored under refrigerated conditions for up to 28 days .
Comparison with Granule Form
A pilot trial comparing omeprazole suspension with granule forms in pediatric patients found no significant differences in blood levels of the drug, indicating that the suspension is a suitable alternative to granules for children .
Conclusion
Omeprazole suspension is an effective and versatile formulation for preventing upper gastrointestinal bleeding in critically ill patients and treating gastric hypersecretion in pediatric patients. Its pharmacokinetic profile, stability, and efficacy make it a valuable option for patients who cannot take solid oral dosage forms.
Sources and full results
Most relevant research papers on this topic
Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension.
After one week of therapy, omeprazole absorption was faster and time to Cmax was 70% shorter for SOS than for the capsule formulation, but AUC0-infinity was 49% lower for SOS.
DOI
Omeprazole nanoparticles suspension: development of a stable liquid formulation with a view to pediatric administration.
Omeprazole nanoparticles suspension effectively protects mice stomachs against ulcer formation, offering a potential pediatric-friendly liquid pharmaceutical form for treating gastric hypersecretion disorders.
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use.
Omeprazole-sodium bicarbonate suspensions for pediatric use maintain high stability and viscosity, even after prolonged storage at room temperature.
DOI